N
NRx Pharmaceuticals
0 followers
NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.
Org chart
Jonathan C. Javitt
Founder & Chief Scientist
Rick Panicucci
Chief Technology Officer
Dennis K. McBride
Chief Strategy Officer & Senior Scientist
Matthew Duffy
Chief Business Officer
Philip T. Lavin
Chief Methodologist
Martin Brecher
Medical Director
M. Daniel Gordin
Regulatory Affairs Officer
Board & advisors
Chaim Hurvitz
Director
Sherry A. Glied
Director
Patrick Flynn
Board Member
Aaron Gorovitz
Director
Daniel C. Javitt
Co-Founder & Chair, Scientific Advisory Board
Wayne Pines
Regulatory & Patient Advocacy Adviser
Melvin L. Morganroth
Clinical Advisor, COVID-19
Harry B. Peled
Clinical Advisor COVID-19
Andrew Nierenberg
Advisor
Marion Leboyer
Advisor